Methotrexate showed promising effects on the positive symptoms of early schizophrenia like auditory and visual hallucinations. — AFP
A study by clinical scientists at the University of Manchester in the United Kingdom has shown that schizophrenia may – in some part – be caused by disordered functioning of the immune system.
The first ever clinical trial in schizophrenia of the powerful immune suppressant drug, methotrexate, produced what the team described as “promising” effects on what are known as positive symptoms, such as hearing voices.
Already a subscriber? Log in.
Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
